Crestor 20Mg Tablet is a medicine used to treat certain types of high blood pressure (hypertension). It contains the active ingredient Rosuvastatin. This medicine is manufactured by AstraZeneca.
Crestor 20Mg Tablet is an oral medicine containing a generic Rosuvastatin formulation. It is available in 20mg, which is a tablet.
Crestor 20Mg Tablet is indicated in adults and children over 12 years old. The medicine is also used for the treatment of heart failure. Crestor 20Mg Tablet may also be used in cases of dyslipidemia and high cholesterol levels.
Crestor 20Mg Tablet is to be taken by mouth with or without food. The dose is usually taken at least 1 hour before sexual activity. It is essential to take the medicine only when needed.
The usual dose of Crestor 20Mg Tablet is one tablet (20 mg) taken with or without food. The recommended dose is one tablet (20 mg) taken with or without food.
The usual daily dosage is one tablet (20 mg) taken with or without food. However, it is important to follow the doctor’s prescribed dosage and treatment schedule. Consult the doctor if the treatment is not working quickly or the symptoms persist.
It is not advisable to stop this medicine suddenly and to consult the doctor if the symptoms worsen. If you have any concerns about the treatment, consult the doctor immediately.
Before using Crestor 20Mg Tablet, inform the doctor about any allergies, other medications, diseases, or allergies, as well as any medical conditions.
Crestor 20Mg Tablet may cause dizziness, so drive or perform other tasks that require alertness before or after dizziness.
To reduce the risk of dizziness and other side effects, avoid driving or operating machinery until you know how Crestor 20Mg Tablet affects you.
Crestor 20Mg Tablet should not be used in children below 12 years.
If you are allergic to Rosuvastatin, you should not use Crestor 20Mg Tablet.
Some medicines may interact with Rosuvastatin and cause allergic reactions. Inform your doctor if you are taking any other medicines, including medicines obtained without a prescription.
Do not use Crestor 20Mg Tablet if you are a woman, a child, or children.
Crestor 20Mg Tablet should not be used in children under 12 years.
If you are taking any of the following medicines, you should seek medical advice before starting Crestor 20Mg Tablet.
Crestor 20Mg Tablet should not be used for treating or preventing any disease.
If you have taken any of the following medicines, you should seek medical advice before starting Crestor 20Mg Tablet.
Do not use Crestor 20Mg Tablet
Crestor 20Mg Tablet should not be used if you are allergic to rosuvastatin, or with other medicines containing rosuvastatin, if you are taking any of the following medicines.
Pregnancy and breastfeeding
Crestor 20Mg Tablet should not be used
Crestor, a statin drug widely used to lower cholesterol, is experiencing significant growth in the pharmaceutical market. It belongs to a class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). These NSAIDs work by inhibiting the production of prostaglandins, enzymes in the body that lead to inflammation, pain, and fever. By reducing prostaglandin production, Crestor helps to lower cholesterol and reduce the risk of cardiovascular disease.
The global cholesterol-lowering drug market was valued at USD 3.64 billion in 2023 and is projected to reach USD 4.57 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.30% from 2024 to 2032[1].
North America is expected to dominant the market, driven by high cholesterol levels and a well-developed market for arthritis and other inflammatory conditions. The high cholesterol levels in this market arise from the fact that high- cholesterol levels are associated with the development of type 2 diabetes. Thus, the focus among industry diversifiers is on reducing the risk of cardiovascular diseases and osteoarthritis in populations with cholesterol levels above the normal limit. The market grows at a CAGR of 3.5% from 2024 to 2032[1].
The Asia-Pacific region is growing at a moderate Compound Annual Growth Rate (CAGR)force it to focus on reducing the incidence and progression of cardiovascular diseases. This growth is due to the increasing prevalence of cardiovascular conditions, which drive an increased demand for inflammatory therapies and drugs. The market grows at a CAGR of 1.5% from 2024 to 2032[1].
Europe is driven by the presence of several high-income countries, such as the UK, Germany, France, and the Netherlands, which offer substantial access to pharmaceutical manufacturers. The region is characterized by a relatively high rate of disease awareness and healthcare access, which drives the demand for statins among this population[1].
Other pharma market players are focusing on lowering cholesterol levels and raising awareness among their customers. These other players include biotechnology companies like biotechnology companies, academic institutions, and pharmaceutical companies. These players are also launching generics, patches, and biosimilars to enhance their product offerings. These launches are expected to continue in the Asia-Pacific region[1][3][4].
is a leading driver of the global cholesterol-lowering drug market, with significant growth potential driven by lifestyle changes and improved health conditions. Lifestyle factors including smoking, regular exercise, and poor diet and dieting practices also contribute to the rising incidence of cholesterol levels. The availability of statin drugs in these areas also helps minimize the risk of cardiovascular side effects. The increasing prevalence of cardiovascular conditions, such as heart disease and stroke, drives the demand for effective treatments[1].
is another significant driver, with significant growth potential. The growing incidence of diabetes, including type 2, highlights the driving need for effective diabetes management strategies. The market can be segmented into high-blood sugar diabetes and low-blood sugar diabetes with high blood sugar levels. These diseases arise due to inadequate blood sugar regulation, which leads to inadequate blood sugar control and low blood sugar levels[4].
The increasing prevalence of cardiovascular conditions, such as heart disease and stroke, drives the demand for effective cardiovascular health medications. The market can be segmented into heart failure, neuroendocrine disorder, and diabetes with heart failure being the leading cause of death in the United States[4].
The financial and insurance coverage of Crestor is straightforward and includes all prescribed and over-the-counter (OTC) products. The product offerings include OTC cholesterol-lowering medicines, arthritis and other inflammatory diseases, generic statins, biosimilars, and injectable medications. The insurance plan covers these products. The cost of Crestor varies based on the form, quantity, and dosage. Some insurance plans cover the cost of Crestor, while others may require a valid prescription from a healthcare provider before reimbursement. Some plans may also require a copay before reimbursement.
A new study in the journal of the American College of Cardiology, which examined the costs of heart surgery, says it may lead to a cost savings of $9 billion to $10 billion a year in Medicare and Medicaid spending.
In a study published in the journal of the American College of Cardiology, researchers examined drug spending data from the largest and most widely prescribed heart surgery program in the United States.
The analysis found that Medicare spending was on par with drug spending in the national average of $10.1 billion last year.
Drugs that cost more than $5,500 more than the national average included: Crestor, Zocor, Claritin, Prevacid, Vioxx and Zocor XR, among others.
The cost of some of the drugs was highest for Crestor, $2.7 million; Zocor, $5.6 million; and Prevacid, $5.8 million. The total cost of Medicare spending for the drugs was $4.1 million, compared with $4.1 million in the national average.
The researchers also found that drug costs were rising for some of the drugs, while other drugs were increasing. These trends were the result of an increased use of generic drugs.
The researchers also found that the cost of the drugs was rising more quickly than the national average of $2.5 million in all-cash payments, as well as the difference between the prices of generic drugs and the prices of branded drugs.
They found that the costs of the drugs that the researchers studied increased by more than one-quarter in all-cash payments as well as the difference between the average prices of generic drugs and the average prices of brand drugs.
The study also looked at the costs of generic drugs.
This means that generic drugs are more expensive than their branded equivalents. Generic drugs are cheaper because the manufacturers of the drugs make a more expensive version of the drug, which is a much better alternative to the brand-name version.
The study shows that the cost of the drugs increased faster than the national average in the 10 years after they began prescribing the drugs. Drug costs are rising in many of these 10 years.
The authors also suggest that the drugs' brand-name costs may be increasing because generic drugs are more expensive than the brand name drugs. They suggest that the drugs' price increases can be due to a combination of factors, including:
The authors also found that the cost of the drugs was increasing. They also found that the drug costs increased faster than the national average.
The researchers also showed that the brand-name drugs cost the same as the generic drugs, or higher. In fact, the brand-name drug prices for generic drugs went up to $2.4 million after they began marketing the drug.
In addition, they said, the costs of the brand name drugs also went up.
The researchers also pointed out that the drugs were not getting older or expensive. They said that while the costs of brand-name drugs increased in the first six months after they started marketing the drug, they were not increasing in the first year after that.
The researchers said that the drugs were increasing in all-cash payments, including the cash payments, because the generics were being used less frequently, which led to an increase in the drugs' prices.
The study said that the cost of the drugs that the researchers looked at was an average of $5.6 million, while the average price of brand-name drugs was $2.7 million.
The researchers also found that the cost of generic drugs increased by more than two-thirds in all-cash payments, while the price of brand-name drugs increased by less than two-thirds.
The study found that the cost of the drugs that the researchers looked at was an average of $5.6 million, while the average price of generic drugs increased by about one-quarter.
The researchers also found that the average prices of generic drugs increased by more than three-quarters, while the average price of brand-name drugs increased by less than one-half.
The drugs that the researchers looked at were generic drugs that were already in the market.
The study said that the drugs that the researchers looked at were still in the market, but the costs of them increased faster than the national average.
The
on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.
Crestor contains the active ingredient ralsuxamol. Ralsuxamol belongs to a group of medicines called statins.
Statins help reduce cholesterol and reduce the risk of heart attack, stroke and other cardiovascular problems. They work by blocking the effects of cholesterol on muscle cells and can be used to lower your risk of heart disease. Your doctor may have you take this medicine before, during or up to a week. If you have heart disease, check your blood pressure, cholesterol levels and the levels of potassium, sodium, magnesium and other important electrolytes. Do not take other medicines unless they have been prescribed by your doctor. Your doctor may tell you to take Crestor with a high-fat meal.
Do not use Crestor if you have ever had an allergic reaction to the active ingredient ralsuxamol or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, are pregnant or plan to become pregnant or are breastfeeding.
Some medicines may interfere with Crestor and affect how well it works. You may need different amounts of your medicines. This could affect how the medicine works or cause side effects.
Crestor is a medicine that comes in a box and you need to open it and shake it well before you take it. You may take it with or without food.
You can take Crestor with or without food.
Follow all directions given to you by your doctor and pharmacist carefully.
Things you should do | Remind any doctor, dentist or pharmacist you visit that you are using Crestor. Tell your doctor immediately if you become pregnant. Do not take Crestor if you are pregnant. Tell your doctor immediately if you are breastfeeding. |
|---|---|
Things you should not do | Do not stop taking Crestor suddenly or change the dose or treatment plan if you are not feeling well or have not been well for more than a few days. |
Stade de France Pharmacy